B. Rawson, N.S. 2020. Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand. Journal of Population Therapeutics and Clinical Pharmacology. 27, 2 (Jun. 2020), e58-e67. DOI:https://doi.org/10.15586/jptcp.v27i2.673.